378 related articles for article (PubMed ID: 25387542)
21. Effects of previous control programmes on the proportion of horses shedding small numbers of strongyle-type eggs.
Lloyd S
Vet Rec; 2009 Jan; 164(4):108-11. PubMed ID: 19168880
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anthelmintic resistant cyathostomes on horse farms.
Kaplan RM; Klei TR; Lyons ET; Lester G; Courtney CH; French DD; Tolliver SC; Vidyashankar AN; Zhao Y
J Am Vet Med Assoc; 2004 Sep; 225(6):903-10. PubMed ID: 15485051
[TBL] [Abstract][Full Text] [Related]
23. A field study on the efficacy of doramectin against strongyles and its egg reappearance period in horses.
Cirak VY; Güleğen E; Yildirim F; Durmaz M
Dtsch Tierarztl Wochenschr; 2007 Feb; 114(2):64-6. PubMed ID: 17341022
[TBL] [Abstract][Full Text] [Related]
24. Time required by different anthelmintics to reach expected efficacy levels in horses infected by strongyles.
Saes IL; Vera JHS; Fachiolli DF; Yamada PH; Dellaqua JVT; Saes RL; Amarante AFT; Soutello RVG
Vet Parasitol; 2016 Oct; 229():90-92. PubMed ID: 27809986
[TBL] [Abstract][Full Text] [Related]
25. Anthelmintic efficacy on UK Thoroughbred stud farms.
Relf VE; Lester HE; Morgan ER; Hodgkinson JE; Matthews JB
Int J Parasitol; 2014 Jul; 44(8):507-14. PubMed ID: 24746779
[TBL] [Abstract][Full Text] [Related]
26. Anthelmintic dosing intervals for horses: comparison of three chemical groups.
Parry JM; Fisher MA; Grimshaw WT; Jacobs DE
Vet Rec; 1993 Oct; 133(14):346-7. PubMed ID: 8236679
[No Abstract] [Full Text] [Related]
27. Prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses.
Tarigo-Martinie JL; Wyatt AR; Kaplan RM
J Am Vet Med Assoc; 2001 Jun; 218(12):1957-60. PubMed ID: 11417741
[TBL] [Abstract][Full Text] [Related]
28. Expulsion of small strongyle nematodes (cyathostomin spp) following deworming of horses on a stud farm in Sweden.
Osterman Lind E; Eysker M; Nilsson O; Uggla A; Höglund J
Vet Parasitol; 2003 Aug; 115(4):289-99. PubMed ID: 12944042
[TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with strongylid egg count prevalence and abundance in the United States equine population.
Nielsen MK; Branan MA; Wiedenheft AM; Digianantonio R; Scare JA; Bellaw JL; Garber LP; Kopral CA; Phillippi-Taylor AM; Traub-Dargatz JL
Vet Parasitol; 2018 Jun; 257():58-68. PubMed ID: 29773232
[TBL] [Abstract][Full Text] [Related]
30. Anthelmintic resistance in nematodes of horses.
Kaplan RM
Vet Res; 2002; 33(5):491-507. PubMed ID: 12387486
[TBL] [Abstract][Full Text] [Related]
31. Detection of Strongylus vulgaris in equine faecal samples by real-time PCR and larval culture - method comparison and occurrence assessment.
Kaspar A; Pfister K; Nielsen MK; Silaghi C; Fink H; Scheuerle MC
BMC Vet Res; 2017 Jan; 13(1):19. PubMed ID: 28077153
[TBL] [Abstract][Full Text] [Related]
32. Eficacy of ivermectin, moxidectin and febendazole in equine in Brazil.
Vera JHS; Fachiolli DF; Ramires LM; de Lima Saes I; Yamada PH; Gonçalves JA; de Oliveira K; do Amarante AFT; de Soutello RVG
Vet Parasitol Reg Stud Reports; 2020 Apr; 20():100374. PubMed ID: 32448518
[TBL] [Abstract][Full Text] [Related]
33. Shedding consistency of strongyle-type eggs in Dutch boarding horses.
Döpfer D; Kerssens CM; Meijer YG; Boersema JH; Eysker M
Vet Parasitol; 2004 Oct; 124(3-4):249-58. PubMed ID: 15381304
[TBL] [Abstract][Full Text] [Related]
34. Strongyle egg reappearance period after moxidectin treatment and its relationship with management factors in UK equine populations.
Tzelos T; Barbeito JS; Nielsen MK; Morgan ER; Hodgkinson JE; Matthews JB
Vet Parasitol; 2017 Apr; 237():70-76. PubMed ID: 28249767
[TBL] [Abstract][Full Text] [Related]
35. Selective therapy in equine parasite control--application and limitations.
Nielsen MK; Pfister K; von Samson-Himmelstjerna G
Vet Parasitol; 2014 May; 202(3-4):95-103. PubMed ID: 24702770
[TBL] [Abstract][Full Text] [Related]
36. Effect of early season ivermectin and pyrantel treatments on strongylid infections in young Shetland ponies in The Netherlands.
Eysker M; Boersema JH; Kooyman FN
Vet Parasitol; 1991 Jan; 38(1):33-9. PubMed ID: 2024428
[TBL] [Abstract][Full Text] [Related]
37. Hierarchical model for evaluating pyrantel efficacy against strongyle parasites in horses.
Nielsen MK; Vidyashankar AN; Hanlon BM; Diao G; Petersen SL; Kaplan RM
Vet Parasitol; 2013 Nov; 197(3-4):614-22. PubMed ID: 23680542
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of ivermectin, pyrantel and fenbendazole against Parascaris equorum infection in foals on farms in Australia.
Armstrong SK; Woodgate RG; Gough S; Heller J; Sangster NC; Hughes KJ
Vet Parasitol; 2014 Oct; 205(3-4):575-80. PubMed ID: 25224788
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and control of equine strongylosis at Newmarket.
Herd RP
Equine Vet J; 1986 Nov; 18(6):447-52. PubMed ID: 3803357
[TBL] [Abstract][Full Text] [Related]
40. Strongyle faecal egg counts in Swiss horses: A retrospective analysis after the introduction of a selective treatment strategy.
Lüthin S; Zollinger A; Basso W; Bisig M; Caspari N; Eng V; Frey CF; Grimm F; Igel P; Lüthi S; Regli W; Roelfstra L; Rosskopf M; Steiner B; Stöckli M; Waidyasekera D; Waldmeier P; Schnyder M; Torgerson PR; Hertzberg H
Vet Parasitol; 2023 Nov; 323():110027. PubMed ID: 37837729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
